KUALA LUMPUR: Pharmaniaga Bhd, through its wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd (PLS) has secured a three-year insulin supply contract valued at RM281.7 million for healthcare facilities nationwide from the Ministry of Health.